Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

• Status: Recruiting
• Trial end date: 2021-12-25
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to assess the safety and efficacy of dexmedetomidine versus ketamine versus midazolam combined with propofol in cancer patients undergoing gastrointestinal endoscopic procedures.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Cancer Institute, Egypt
• Treatments: Dexmedetomidine; Ketamine; Midazolam; Propofol

Criteria

Inclusion Criteria:

• patients scheduled for gastrointestinal endoscopic procedures

• ≥ Age 18 years

• ASA I-II

Exclusion Criteria:

• Allergy to any of the used drugs

• impaired renal or liver functions

• hypertensive patients

• patients with cardiovascular

• cerebrovascular disease